This study highlights new regulatory mechanism by which serine tailors the immune responses of macrophages, implicating serine metabolism, and mTOR signaling as potential therapeutic targets for macrophage-associated diseases (e.g., cancer, obesity, and pathogen infection). This evidence concerns the gene MTOR and obesity disorder.